Profiles

Keywords
Last Name
Institution

Sefer Gezer

TitleProfessor
InstitutionRush University, Rush Medical College
DepartmentInternal Medicine, Division of Hematology/Oncology/Cell Therapy
Address
vCardDownload vCard

    Collapse Overview 
    Collapse overview
    My Scopus ID is 6603856801.


    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Rao S, Warrior S, Luo S, Gezer S, Venugopal P, Jain S. Impact of blood type on thrombosis and disease severity in adult COVID-19 patients. Thromb Res. 2021 10; 206:145-147. PMID: 34482228.
      View in: PubMed
    2. Warrior S, Behrens E, Thomas J, Gezer S, Venugopal P, Jain S. Prevention of Thromboembolic Events in Patients with COVID-19. TH Open. 2021 Jul; 5(3):e415-e419. PMID: 34595386.
      View in: PubMed
    3. Bedair H, Berli M, Gezer S, Jacobs JJ, Della Valle CJ. Hematologic genetic testing in high-risk patients before knee arthroplasty: a pilot study. Clin Orthop Relat Res. 2011 Jan; 469(1):131-7. PMID: 20824408.
      View in: PubMed
    4. Khandelwal A, Shah NB, Eichenseer P, Welker M, Miller I, Nangia J, Farhat M, Gimelfarb A, Kassar M, Batus M, Gezer S, Shammo J, Gregory S, Fung H, Venugopal P. Idiopathic hemophagocytic syndrome with a fulminant clinical course. Clin Adv Hematol Oncol. 2008 Aug; 6(8):587-90. PMID: 18820601.
      View in: PubMed
    5. Raza A, Candoni A, Khan U, Lisak L, Tahir S, Silvestri F, Billmeier J, Alvi MI, Mumtaz M, Gezer S, Venugopal P, Reddy P, Galili N. Remicade as TNF suppressor in patients with myelodysplastic syndromes. Leuk Lymphoma. 2004 Oct; 45(10):2099-104. PMID: 15370256.
      View in: PubMed
    6. Raza A, Buonamici S, Lisak L, Tahir S, Li D, Imran M, Chaudary NI, Pervaiz H, Gallegos JA, Alvi MI, Mumtaz M, Gezer S, Venugopal P, Reddy P, Galili N, Candoni A, Singer J, Nucifora G. Arsenic trioxide and thalidomide combination produces multi-lineage hematological responses in myelodysplastic syndromes patients, particularly in those with high pre-therapy EVI1 expression. Leuk Res. 2004 Aug; 28(8):791-803. PMID: 15203277.
      View in: PubMed
    7. Gezer S. Antiphospholipid syndrome. Dis Mon. 2003 Dec; 49(12):696-741. PMID: 14679358.
      View in: PubMed
    8. Zorat F, Shetty V, Dutt D, Lisak L, Nascimben F, Allampallam K, Dar S, York A, Gezer S, Venugopal P, Raza A. The clinical and biological effects of thalidomide in patients with myelodysplastic syndromes. Br J Haematol. 2001 Dec; 115(4):881-94. PMID: 11843822.
      View in: PubMed
    9. Alvi S, Shaher A, Shetty V, Henderson B, Dangerfield B, Zorat F, Joshi L, Anthwal S, Lisak L, Little L, Gezer S, Mundle S, Reddy PL, Allampallam K, Huang X, Galili N, Borok RZ, Raza A. Successful establishment of long-term bone marrow cultures in 103 patients with myelodysplastic syndromes. Leuk Res. 2001 Nov; 25(11):941-54. PMID: 11597729.
      View in: PubMed
    10. Raza A, Meyer P, Dutt D, Zorat F, Lisak L, Nascimben F, du Randt M, Kaspar C, Goldberg C, Loew J, Dar S, Gezer S, Venugopal P, Zeldis J. Thalidomide produces transfusion independence in long-standing refractory anemias of patients with myelodysplastic syndromes. Blood. 2001 Aug 15; 98(4):958-65. PMID: 11493439.
      View in: PubMed
    11. Preisler HD, Venugopal P, Gregory SA, Adler S, Gezer S, Hsu WT, Manson S, Larson A, Jajeh A, Slvinick D, Galvez A. High remission rate in acute myeloblastic leukemia with only two days of chemotherapy. Leuk Lymphoma. 2001 Apr; 41(3-4):333-6. PMID: 11378545.
      View in: PubMed
    12. Preisler HD, Venugopal P, Gregory SA, Hsu W, Loew J, Adler S, Gezer S, Creech S, Galvez A, Slivnick D, Andric T, Larson RA, Jajeh A. Poor prognosis acute myelogenous leukemia: 1 - response to treatment with high dose cytarabine/mitoxantrone/ethyol @ (Amifostine). Leuk Res. 2000 Aug; 24(8):671-80. PMID: 10936421.
      View in: PubMed
    13. Raza A, Qawi H, Lisak L, Andric T, Dar S, Andrews C, Venugopal P, Gezer S, Gregory S, Loew J, Robin E, Rifkin S, Hsu WT, Huang RW. Patients with myelodysplastic syndromes benefit from palliative therapy with amifostine, pentoxifylline, and ciprofloxacin with or without dexamethasone. Blood. 2000 Mar 01; 95(5):1580-7. PMID: 10688811.
      View in: PubMed
    14. Raza A, Qawi H, Andric T, Dar S, Lisak L, Huang RW, Venugopal P, Gezer S, Gregory SA, Hsu WT, Loew J, Robin E, Rifkin S, Shah R, Divgi A, Taylor R, Grosset A. Pentoxifylline, Ciprofloxacin and Dexamethasone Improve the Ineffective Hematopoiesis in Myelodysplastic Syndrome Patients; Malignancy. Hematology. 2000; 5(4):275-284. PMID: 11399622.
      View in: PubMed
    15. Goyal R, Qawi H, Ali I, Dar S, Mundle S, Shetty V, Mativi Y, Allampallam K, Lisak L, Loew J, Venugopal P, Gezer S, Robin E, Rifkin S, Raza A. Biologic characteristics of patients with hypocellular myelodysplastic syndromes. Leuk Res. 1999 Apr; 23(4):357-64. PMID: 10229321.
      View in: PubMed
    16. Dar S, Mundle S, Andric T, Qawi H, Shetty V, Reza S, Mativi BY, Allampallam K, Ali A, Venugopal P, Gezer S, Broady-Robinson L, Cartlidge J, Showel M, Hussaini S, Ragasa D, Ali I, Chaudhry A, Waggoner S, Lisak L, Huang RW, Raza A. Biological characteristics of myelodysplastic syndrome patients who demonstrated high versus no intramedullary apoptosis. Eur J Haematol. 1999 Feb; 62(2):90-4. PMID: 10052711.
      View in: PubMed
    17. Yorulmazoglu E, Gezer S, Gregory SA, Hsu WT. Acute promyelocytic leukemia (APL) with an unusual cytogenetic presentation. Med Pediatr Oncol. 1998 Jan; 30(1):69-72. PMID: 9371394.
      View in: PubMed
    18. Raza A, Alvi S, Broady-Robinson L, Showel M, Cartlidge J, Mundle SD, Shetty VT, Borok RZ, Dar SE, Chopra HK, Span L, Parcharidou A, Hines C, Gezer S, Venugopal P, Loew J, Showel J, Alston D, Hernandez B, Rifkin S, Robin E, Shah R, Gregory SA. Cell cycle kinetic studies in 68 patients with myelodysplastic syndromes following intravenous iodo- and/or bromodeoxyuridine. Exp Hematol. 1997 Jun; 25(6):530-5. PMID: 9197332.
      View in: PubMed
    19. Shetty V, Mundle S, Alvi S, Showel M, Broady-Robinson L, Dar S, Borok R, Showel J, Gregory S, Rifkin S, Gezer S, Parcharidou A, Venugopal P, Shah R, Hernandez B, Klein M, Alston D, Robin E, Dominquez C, Raza A. Measurement of apoptosis, proliferation and three cytokines in 46 patients with myelodysplastic syndromes. Leuk Res. 1996 Nov-Dec; 20(11-12):891-900. PMID: 9009245.
      View in: PubMed
    20. Mundle SD, Venugopal P, Cartlidge JD, Pandav DV, Broady-Robinson L, Gezer S, Robin EL, Rifkin SR, Klein M, Alston DE, Hernandez BM, Rosi D, Alvi S, Shetty VT, Gregory SA, Raza A. Indication of an involvement of interleukin-1 beta converting enzyme-like protease in intramedullary apoptotic cell death in the bone marrow of patients with myelodysplastic syndromes. Blood. 1996 Oct 01; 88(7):2640-7. PMID: 8839858.
      View in: PubMed
    21. Raza A, Mundle S, Shetty V, Alvi S, Chopra H, Span L, Parcharidou A, Dar S, Venugopal P, Borok R, Gezer S, Showel J, Loew J, Robin E, Rifkin S, Alston D, Hernandez B, Shah R, Kaizer H, Gregory S, Preisler H. A paradigm shift in myelodysplastic syndromes. Leukemia. 1996 Oct; 10(10):1648-52. PMID: 8847900.
      View in: PubMed
    22. Raza A, Mundle S, Shetty V, Alvi S, Chopra H, Span L, Parcharidou A, Dar S, Venugopal P, Borok R, Gezer S, Showel J, Loew J, Robin E, Rifkin S, Alston D, Hernandez B, Shah R, Kaizer H, Gregory S. Novel insights into the biology of myelodysplastic syndromes: excessive apoptosis and the role of cytokines. Int J Hematol. 1996 Jun; 63(4):265-78. PMID: 8762810.
      View in: PubMed
    23. Raza A, Gezer S, Mundle S, Gao XZ, Alvi S, Borok R, Rifkin S, Iftikhar A, Shetty V, Parcharidou A, et al. Apoptosis in bone marrow biopsy samples involving stromal and hematopoietic cells in 50 patients with myelodysplastic syndromes. Blood. 1995 Jul 01; 86(1):268-76. PMID: 7795232.
      View in: PubMed
    24. Raza A, Gezer S, Anderson J, Lykins J, Bennett J, Browman G, Goldberg J, Larson R, Vogler R, Preisler HD. Relationship of [3H]Ara-C incorporation and response to therapy with high-dose Ara-C in AML patients: a Leukemia Intergroup study. Exp Hematol. 1992 Nov; 20(10):1194-200. PMID: 1426099.
      View in: PubMed
    25. Kolluri RV, Manuelidis L, Cremer T, Sait S, Gezer S, Raza A. Detection of monosomy 7 in interphase cells of patients with myeloid disorders. Am J Hematol. 1990 Feb; 33(2):117-22. PMID: 2301370.
      View in: PubMed
    26. Raza A, Imren S, Gezer S, Verkh L, Freeman JW. Expression of nucleolar antigen p145 in bone marrow cells of patients with myeloid leukemias. Cancer Res. 1989 Jan 15; 49(2):482-7. PMID: 2910466.
      View in: PubMed
    27. Raza A, Gezer S, Mehdi I, Preisler HD. Detection of BrdU in the regenerating bone marrow cells of a patient with AML. Leuk Res. 1989; 13(12):1055-9. PMID: 2615464.
      View in: PubMed
    28. Gezer S, Yasin Z, Imren S, Freeman J, Black A, Raza A. Changes observed in the growth fraction, labeling index, duration of S phase, and total cell cycle times of HL-60 cells as they undergo differentiation in response to retinoic acid. Cancer Res. 1988 Nov 01; 48(21):5989-94. PMID: 2844395.
      View in: PubMed
    Gezer's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    See all (151) concept(s)
    _
    Co-Authors Expand Description
    See all (6) people
    _
    Similar People Expand Description
    See all (60) people
    _
    Same Department Expand Description
    Search Department